Jonathan Allan, GENERAL COUNSEL & Corporate Secretary at Stoke Therapeutics, Inc. (STOK), sold 10,152 shares at $13.19 ($134K) on 2024-03-28, disclosed to the SEC on 2024-04-01.
Scheduled sale ($134k) by GENERAL COUNSEL & Corporate Secretary under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.19 | 5,026 | $66K | 49.5% |
| 2 | $13.19 | 5,026 | $66K | 49.5% |
| 3 | $13.81 | 100 | $1K | 1.0% |
| Total | $13.20 avg | 10,152 | $134K | 100% |
| Filing → |
| STOK | SELL | 2026-06-18 | $44K | — | Filing → |
| STOK | SELL | 2026-03-24 | $626K | — | Filing → |
| STOK | SELL | 2026-03-19 | $569K | — | Filing → |